Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
10.57
-0.16 (-1.49%)
Feb 23, 2026, 4:00 PM EST - Market closed
Embecta Revenue
Embecta had revenue of $261.20M in the quarter ending December 31, 2025, a decrease of -0.27%. This brings the company's revenue in the last twelve months to $1.08B, down -2.53% year-over-year. In the fiscal year ending September 30, 2025, Embecta had annual revenue of $1.08B, down -3.80%.
Revenue (ttm)
$1.08B
Revenue Growth
-2.53%
P/S Ratio
0.58
Revenue / Employee
$583,622
Employees
1,850
Market Cap
625.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 1.08B | -42.70M | -3.80% |
| Sep 30, 2024 | 1.12B | 2.30M | 0.21% |
| Sep 30, 2023 | 1.12B | -8.70M | -0.77% |
| Sep 30, 2022 | 1.13B | -35.80M | -3.07% |
| Sep 30, 2021 | 1.17B | 79.80M | 7.35% |
| Sep 30, 2020 | 1.09B | -23.50M | -2.12% |
| Sep 30, 2019 | 1.11B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Azenta | 595.03M |
| AtriCure | 534.53M |
| AngioDynamics | 307.31M |
| STAAR Surgical Company | 230.59M |
| BioLife Solutions | 100.14M |
| Kestra Medical Technologies | 74.26M |
| KORU Medical Systems | 39.07M |
| Utah Medical Products | 38.52M |
EMBC News
- 12 days ago - embecta names new Chairman of the Board and Lead Independent Director - GlobeNewsWire
- 18 days ago - Embecta Corp. (EMBC) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results - GlobeNewsWire
- 19 days ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 4 weeks ago - embecta to Report Fiscal First Quarter Financial Results - GlobeNewsWire
- 5 weeks ago - Embecta Corp. (EMBC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - embecta to Participate at the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 3 months ago - Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade) - Seeking Alpha